Study of RH-1 in Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00558727 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Non-Hodgkin's Lymphoma

Interventions

DRUG: RH-1

Sponsor

Spectrum Pharmaceuticals, Inc